These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15637074)

  • 1. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
    Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
    J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
    Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
    Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells.
    Sarret P; Gendron L; Kilian P; Nguyen HM; Gallo-Payet N; Payet MD; Beaudet A
    J Biol Chem; 2002 Sep; 277(39):36233-43. PubMed ID: 12084713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and expression of a variant isoform of the levocabastine-sensitive neurotensin receptor in the mouse central nervous system.
    Botto JM; Sarret P; Vincent JP; Mazella J
    FEBS Lett; 1997 Jan; 400(2):211-4. PubMed ID: 9001400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation.
    Toy-Miou-Leong M; Cortes CL; Beaudet A; Rostène W; Forgez P
    J Biol Chem; 2004 Mar; 279(13):12636-46. PubMed ID: 14699144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
    Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
    Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand.
    Tóth F; Mallareddy JR; Tourwé D; Lipkowski AW; Bujalska-Zadrozny M; Benyhe S; Ballet S; Tóth G; Kleczkowska P
    Neuropeptides; 2016 Jun; 57():15-20. PubMed ID: 26707235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
    Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
    Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
    ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
    Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
    Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.
    Dal Farra C; Sarret P; Navarro V; Botto JM; Mazella J; Vincent JP
    Int J Cancer; 2001 May; 92(4):503-9. PubMed ID: 11304684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
    Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide.
    Cusack B; Groshan K; McCormick DJ; Pang YP; Perry R; Phung CT; Souder T; Richelson E
    J Biol Chem; 1996 Jun; 271(25):15054-9. PubMed ID: 8662846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimerization of apelin receptor and neurotensin receptor 1 induces phosphorylation of ERK(1/2) and cell proliferation via Gαq-mediated mechanism.
    Bai B; Cai X; Jiang Y; Karteris E; Chen J
    J Cell Mol Med; 2014 Oct; 18(10):2071-81. PubMed ID: 25164432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained neurotensin exposure promotes cell surface recruitment of NTS2 receptors.
    Perron A; Sharif N; Gendron L; Lavallée M; Stroh T; Mazella J; Beaudet A
    Biochem Biophys Res Commun; 2006 May; 343(3):799-808. PubMed ID: 16564027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a soluble cadherin-7 isoform produced by alternative splicing.
    Kawano R; Matsuo N; Tanaka H; Nasu M; Yoshioka H; Shirabe K
    J Biol Chem; 2002 Dec; 277(49):47679-85. PubMed ID: 12364338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system.
    Sarret P; Perron A; Stroh T; Beaudet A
    J Comp Neurol; 2003 Jul; 461(4):520-38. PubMed ID: 12746866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization.
    Hermans E; Octave JN; Maloteaux JM
    Mol Pharmacol; 1996 Feb; 49(2):365-72. PubMed ID: 8632771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.
    Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P
    ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.